1998
DOI: 10.1182/blood.v92.10.3898.422k03_3898_3903
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins

Abstract: Defensins are small, cationic antimicrobial peptides that are present in the azurophilic granules of neutrophils. Earlier studies have shown that defensins may influence complement activation by specific interaction with activated C1, C1q, and C1-inhibitor. In the present study, we show that the defensin human neutrophil peptide-1 (HNP-1) is able to inhibit activation of the classical complement pathway by inhibition of C1q hemolytic activity. The binding site for HNP-1 on C1q is most likely located on the col… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(19 citation statements)
references
References 36 publications
0
19
0
Order By: Relevance
“…Due to their abundance in neutrophilic granulocytes, they were termed human neutrophil defensins (HNPs). 5 including antiviral activity [6][7][8][9] Chemo-attracts monocytes, T-cells and dendritic cells [11][12][13][14] Inhibition of complement activation 223,224 Activation of mast cells 67…”
Section: Human Neutrophil α α-Defensin Peptides (Hnps 1-4)mentioning
confidence: 99%
“…Due to their abundance in neutrophilic granulocytes, they were termed human neutrophil defensins (HNPs). 5 including antiviral activity [6][7][8][9] Chemo-attracts monocytes, T-cells and dendritic cells [11][12][13][14] Inhibition of complement activation 223,224 Activation of mast cells 67…”
Section: Human Neutrophil α α-Defensin Peptides (Hnps 1-4)mentioning
confidence: 99%
“…Defensins may also participate in the immune response by causing neutrophil activation 201 and modulating the activity of the classical complement pathway by binding to complement C1q. 202,203 The aforementioned ability of defensins to inhibit adrenocorticotrophin activity, 180 and, therefore, reduce production of anti-inflammatory glucocorticoids, may also be a mechanism by which these peptides can enhance the immune response. Additionally, LL-37 is able to bind and neutralize lipopolysaccharide and lipotechoic acid, and, thus, reduce the inflammatory response associated with these molecules.…”
Section: Nonmicrobicidal Roles Of Defensins and Other Antimicrobiamentioning
confidence: 99%
“…These peptides may further increase the production of tumor necrosis factor (TNF) and interleukin-1 (IL-1), and reduce the production of anti-inflammatory interleukin 10 (IL-10) [7,8]. Alpha-defensins act chemotactically on CD8 T lymphocytes, immature dendritic cells, and immature T lymphocytes, enhancing or suppressing activation of the classical complement pathway [9,10].…”
Section: Discussionmentioning
confidence: 99%